European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Issue 10 (October 2022)

• Record Type: Journal Article
• Authors: Bischoff, Stephan C.; Barazzoni, Rocco; Busetto, Luca; Campmans-Kuijpers, Marjo; Cardinale, Vincenzo; Chermesh, Irit; Eshraghian, Ahad; Kani, Haluk Tarik; Khannoussi, Wafaa; Lacaze, Laurence; Léon-Sanz, Miguel; Mendive, Juan M.; Müller, Michael W.; Ockenga, Johann; Tacke, Frank; Thorell, Anders; Vranesic Bender, Darija; Weimann, Arved; Cuerda, Cristina
• Is Part Of: Clinical nutrition. Volume 41:Issue 10(2022)
• Page Start: 2364
• Page End: 2405
• Publication Date: 2022-10
• Subjects: Obesity -- Sarcopenic obesity -- Inflammatory bowel disease -- Non-alcoholic fatty liver disease -- Bariatric surgery; Critically ill -- Nutrition -- Periodicals; Diet therapy -- Periodicals; Parenteral feeding -- Periodicals; Enteral feeding -- Periodicals; Enteral Nutrition -- Periodicals; Parenteral Nutrition -- Periodicals; Metabolism -- Periodicals; Diétothérapie -- Périodiques; Alimentation parentérale -- Périodiques; Alimentation entérale -- Périodiques; Nutrition -- Périodiques; Diet therapy; Enteral feeding; Nutrition; Parenteral feeding; Electronic journals; Periodicals; Electronic journals; 615.854
• DOI: 10.1016/j.clnu.2022.07.003
• Languages: English
• ISSNs: 0261-5614

Abstract

Summary: Background: Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence. Objective: The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity. Methods: The present guideline was developed according to the standard operating procedure for ESPEN guidelines, following the Scottish Intercollegiate Guidelines Network (SIGN) grading system (A, B, 0, and good practice point (GPP)). The procedure included an online voting (Delphi) and a final consensus conference. Results: In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity – including sarcopenic obesity – is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician. Conclusion: The present guideline offers for the first time evidence-based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.